Acorda Therapeutics Inc EV / EBITDA
Cos'è EV / EBITDA di Acorda Therapeutics Inc?
EV / EBITDA di Acorda Therapeutics Inc è N/A
Qual è la definizione di EV / EBITDA?
EV / EBITDA è il valore aziendale diviso per guadagni prima di interessi, tasse, deprezzamento e ammortamento. È una misura di quanto sia costosa una azione ed è più frequentemente valida per i confronti tra le aziende rispetto al rapporto prezzo / guadagno. Misura il prezzo (sotto forma di valore d'impresa) che un investitore paga a vantaggio del flusso di cassa della società (sotto forma di EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA di aziende nel Health Care settore su NASDAQ rispetto a Acorda Therapeutics Inc
Cosa fa Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Aziende con ev / ebitda simili a Acorda Therapeutics Inc
- Jia Yao ha EV / EBITDA di N/A
- CLS USA ha EV / EBITDA di N/A
- Overseas Chinese Town (Asia) ha EV / EBITDA di N/A
- Starr Peak Exploration ha EV / EBITDA di N/A
- Good Friend International ha EV / EBITDA di N/A
- DoorDash Inc ha EV / EBITDA di N/A
- Acorda Therapeutics Inc ha EV / EBITDA di N/A
- Inspur International ha EV / EBITDA di N/A
- Setubandhan Infrastructure ha EV / EBITDA di N/A
- Avalon Works ha EV / EBITDA di N/A
- Galileo Mining Ltd ha EV / EBITDA di N/A
- Trine Acquisition ha EV / EBITDA di N/A
- Dreadnought Resour ha EV / EBITDA di N/A